Reply to: Utilizing foundation models for developing clinical tools.

Zhang, Juzhao; Lin, Senlin; Zou, Haidong; Ma, Yingyan · NPJ Digit Med · 2025

editorial · Level V

Where this comes from

Abstract

This reply addresses Chan et al.'s comments on our previous study, clarifying the use of foundation models (e.g., RETFound), commercial data sources/anonymity, and DeLong test results. We highlight that the SDEDS-fine-tuned RETFound outperforms commercial models and acknowledge the need for further testing, while referencing an early benchmark value.